A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation

Human Vaccines and Immunotherapeutics

Volumn 14, Issue 4, 2018, Pages 969-977

  Panatto, Donatella ^a   Amicizia, Daniela ^a   Arata, Lucia ^a   Lai, Piero Luigi ^a   Gasparini, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

influenza; Influenza vaccines; internet; misinformation; squalene; squalene based adjuvants; vaccine adjuvants

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; SQUALENE BASED VACCINE ADJUVANT; UNCLASSIFIED DRUG; VIRUS VACCINE; SQUALENE; VIRUS ANTIBODY;

ADJUVANT THERAPY; ANTI-VACCINATION MOVEMENT; ARTICLE; AUTISM; AUTOIMMUNE DISEASE; DECISION MAKING; HUMAN; INTERNET; PERSIAN GULF SYNDROME; VIDEORECORDING; EVALUATION STUDY; IMMUNOLOGY; INFLUENZA; ITALY; PANDEMIC; PREVALENCE;

ADJUVANTS, IMMUNOLOGIC; ANTIBODIES, VIRAL; EVALUATION STUDIES AS TOPIC; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNET; ITALY; PANDEMICS; PREVALENCE; SQUALENE;

EID: 85043355303     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2017.1407483     Document Type: Article

References (67)

1. Kelly GS. Squalene and its potential clinical uses. Altern Med Rev. 1999;4(1):29–36. PMID:9988781.
2. Huang ZR, Lin YK, Fang JY. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 2009;14(1):540–54. doi:10.3390/molecules14010540. PMID:19169201.
3. Wołosik K, Knaś M, Zalewska A, Niczyporuk M, Przystupa AW. The importance and perspective of plant-based squalene in cosmetology. J Cosmet Sci. 2013;64(1):59–66. PMID:23449131.
4. Smith TJ. Squalene: potential chemopreventive agent. Expert Opin Investig Drugs. 2000;9(8):1841–8. doi:10.1517/13543784.9.8.1841. PMID:11060781.
5. Zhang Z, Yeung WK, Huang Y, Chen ZY. Effect of squalene and shark liver oil on serum cholesterol level in hamsters. Int J Food Sci Nutr. 2002;53(5):411–8. doi:10.1080/0963748021000044750. PMID:12396466.
6. Fox CB, Haensler J. An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Rev Vaccines. 2013;12(7):747–58. doi:10.1586/14760584.2013.811188. PMID:23885820.
7. Lee S, Nguyen MT. Recent advances of vaccine adjuvants for infectious diseases. Immune Netw. 2015;15(2):51–7. doi:10.4110/in.2015.15.2.51. PMID:25922593.
8. Di Pasquale A, Preiss S, Tavares Da Silva F, Garçon N. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines (Basel). 2015 Apr 16;3(2):320–43. doi:10.3390/vaccines3020320.
9. Lansbury LE, Smith S, Beyer W, Karamehic E, Pasic-Juhas E, Sikira H, Mateus A, Oshitani H, Zhao H, Beck CR, et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis. Vaccine. 2017;35(16):1996–2006. doi:10.1016/j.vaccine.2017.02.059. PMID:28302409.
10. Levi M, Sinisgalli E, Lorini C, Santomauro F, Chellini M, Bonanni P. The “Fluad Case” in Italy: Could it have been dealt differently? Hum Vaccin Immunother. 2017;13(2):379–384. doi:10.1080/21645515.2017.1264738. PMID:27924687.
11. Signorelli C, Odone A, Conversano M, Bonanni P. Deaths after Fluad flu vaccine and the epidemic of panic in Italy. BMJ. 2015;350:h116. doi:10.1136/bmj.h116. PMID:25589037.
12. Siliquini R, Ceruti M, Lovato E, Bert F, Bruno S, De Vito E, Liguori G, Manzoli L, Messina G, Minniti D, et al. Surfing the internet for health information: an Italian survey on use and population choices. BMC Med Inform Decis Mak. 2011;11:21. doi:10.1186/1472-6947-11-21. PMID:21470435.
13. Tannous LK, Barlow G, Metcalfe NH. A short clinical review of vaccination against measles. JRSM Open. 2014;5(4):2054270414523408. doi:10.1177/2054270414523408. PMID:25057386.
14. Ford JA, Mahgoub H, Shankar AG. Vaccine acceptance: the UK perspective. Hum Vaccin Immunother. 2013;9(12):2658–60. doi:10.4161/hv.26411. PMID:24025731.
15. Kata A. A postmodern Pandora's box: anti-vaccination misinformation on the Internet. Vaccine. 2010;28(7):1709–16. doi:10.1016/j.vaccine.2009.12.022. PMID:20045099.
16. Tafuri S, Gallone MS, Gallone MF, Zorico I, Aiello V, Germinario C. Communication about vaccinations in Italian websites: a quantitative analysis. Hum Vaccin Immunother. 2014;10(5):1416–20. doi:10.4161/hv.28268. PMID:24607988.
17. Fu LY, Zook K, Spoehr-Labutta Z, Hu P, Joseph JG. Search engine ranking, quality, and content of web pages that are critical versus noncritical of human papillomavirus vaccine. J Adolesc Health. 2016;58(1):33–9. doi:10.1016/j.jadohealth.2015.09.016. PMID:26559742.
18. Google trends [accessed 2017May2]. https://trends.google.com/trends/explore?cat=45&geo=IT&q=squalene.
19. Pitrelli A. Introduction of a quadrivalent influenza vaccine in Italy: a budget impact analysis. J Prev Med Hyg. 2016;57:E34–E40. PMID:27346938.
20. Italian Ministry of Health. Vaccination coverage [accessed 2017May2]. http://www.salute.gov.it/portale/influenza/dettaglioContenutiInfluenza.jsp?lingua=italiano&id=679&area=influenza&menu=vuoto.
21. Offit PA, Coffin SE. Communicating science to the public: MMR vaccine and autism. Vaccine. 2003;22(1):1–6. doi:10.1016/S0264-410X(03)00532-2. PMID:14604564.
22. Yu W, Liu D, Zheng J, Liu Y, An Z, Rodewald L, Zhang G, Su Q, Li K, Xu D, et al. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China. Int J Epidemiol. 2016;45(2):441–9. doi:10.1093/ije/dyv349. PMID:27174834.
23. Nan X, Madden K. HPV vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions. Health Commun. 2012;27:829–36. doi:10.1080/10410236.2012.661348. PMID:22452582.
24. Poscia A, Santoro A, Collamati A, Giannetti G, de Belvis AG, Ricciardi W, Moscato U. Availability and quality of vaccines information on the Web: a systematic review and implication in Public Health. Ann Ig. 2012;24(2):113–21. PMID:22755498.
25. Tozzi AE, Buonuomo PS, Ciofi degli Atti ML, Carloni E, Meloni M, Gamba F. Comparison of quality of internet pages on human papillomavirus immunization in Italian and in English. J Adolesc Health. 2010;46(1):83–9. doi:10.1016/j.jadohealth.2009.05.006. PMID:20123262.
26. Okushara T, Ishikawa H, Okada M, Kato M, Kiuchi T. A readability comparison of anti- versus pro-influenza vaccination online messages in Japan. Prev Med Rep. 2017;6:47–52. doi:10.1016/j.pmedr.2017.02.013. PMID:28271020.
27. Terranova G, Ferro M, Carpeggiani C, Recchia V, Braga L, Semelka RC, Picano E. Low quality and lack of clarity of current informed consent forms in cardiology: how to improve them. JACC Cardiovasc Imaging. 2012;5(6):649–55. doi:10.1016/j.jcmg.2012.03.007. PMID:22698536.
28. Boles DB. Dissociated imageability, concreteness, and familiarity in lateralized word recognition. Mem Cogn. 1983;11(5):511–9. doi:10.3758/BF03196988.
29. Blaskiewicz R. The Big Pharma conspiracy theory. Med Writ. 2013;22(4):259–61. doi:10.1179/2047480613Z.000000000142.
30. Nettleman M. Gulf war illness: challenges persist. Trans Am Clin Climatol Assoc. 2015;126:237–47. PMID:26330683.
31. Matyas GR, Rao M, Pittman PR, Burge R, Robbins IE, Wassef NM, Thivierge B, Alving CR. Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods. 2004;286(1-2):47–67. doi:10.1016/j.jim.2003.11.002. PMID:15087221.
32. Phillips CJ, Matyas GR, Hansen CJ, Alving CR, Smith TC, Ryan MA. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. Vaccine. 2009;27(29):3921–6. doi:10.1016/j.vaccine.2009.03.091. PMID:19379786.
33. Del Giudice G, Fragapane E, Bugarini R, Hora M, Henriksson T, Palla E, O'Hogan D, Donnelly J, Rappuoli R, Podda A. Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene. Clin Vaccine Immunol. 2006;13(9):1010–3. doi:10.1128/CVI.00191-06. PMID:16960112.
34. Federal Register. Biological products; bacterial vaccines and toxoids; implementation of efficacy review; anthrax vaccine adsorbed; final order. Fed Regist. 2005;70:75180–98.
35. Shim SM, Seo SH, Lee Y, Moon GI, Kim MS, Park JH. Consumers' knowledge and safety perceptions of food additives: evaluation on the effectiveness of transmitting information on preservatives. Food Control. 2011;22(7):1054–60. doi:10.1016/j.foodcont.2011.01.001.
36. Dickson-Spillmann M, Siegrist M, Keller C. Attitudes toward chemicals are associated with preference for natural food. Food Qual Preference. 2011;22(1):149–56. doi:10.1016/j.foodqual.2010.09.001.
37. Eurostat. Digital economy and society statistics–households and individuals [accessed 2017May2]. http://ec.europa.eu/eurostat/statistics-explained/index.php/Digital_economy_and_society_statistics_-_households_and_individuals.
38. Freed GL, Katz SL, Clark SJ. Safety of vaccinations. Miss America, the media, and public health. JAMA. 1996;276(23):1869–72. doi:10.1001/jama.1996.03540230019013. PMID:8968002.
39. Murray E, Lo B, Pollack L, Donelan K, Catania J, Lee K, Zapert K, Turner R. The impact of health information on the Internet on health care and the physician-patient relationship: national U.S. survey among 1.050 U.S. physicians. J Med Internet Res. 2003;5(3):e17. doi:10.2196/jmir.5.3.e17. PMID:14517108.
40. Panatto D, Domnich A, Gasparini R, Bonanni P, Icardi G, Amicizia D, Arata L, Bragazzi NL, Signori A, Landa P, et al. Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention. Hum Vaccin Immunother. 2016;12(4):1080–4. doi:10.1080/21645515.2015.1114196. PMID:26795065.
41. Panatto D, Domnich A, Gasparini R, Bonanni P, Icardi G, Amicizia D, Arata L, Carozzo S, Signori A, Bechini A, et al. An eHealth project on invasive pneumococcal disease: comprehensive evaluation of a promotional campaign. J Med Internet Res. 2016;18(12):e316. doi:10.2196/jmir.6205. PMID:27913372.
42. Society of Professional Journalists (SPJ). SPJ code of ethics. [accessed 2017October23]. https://www.spj.org/ethicscode.asp
43. Chadwick R. Bioethics in a Post-Truth Era. Bioethics. 2017;31(3):154. doi:10.1111/bioe.12344. PMID:28220560.
44. Iannazzo S. Pharmacoeconomic evaluation of the MF59-adjuvanted influenza vaccine in the elderly population in Italy. J Prev Med Hyg. 2011;52(1):1–8. PMID:21710816.
45. Meats E, Brassey J, Heneghan C, Glasziou P. Using the turning research into practice (TRIP) database: how do clinicians really search? J Med Libr Assoc. 2007;95(2):156–63. doi:10.3163/1536-5050.95.2.156. PMID:17443248.
46. Jansen BJ, Pooch U. A review of Web searching studies and a framework for future research. J Am Soc Inf Sci Technol. 2001;52(3):235–46. doi:10.1002/1097-4571(2000)9999:9999%3c::AID-ASI1607%3e3.0.CO;2-F.
47. Eysenbach G, Köhler C. How do consumers search for and appraise health information on the world wide web? Qualitative study using focus groups, usability tests, and in-depth interviews. BMJ. 2002;324(7337):573–7. doi:10.1136/bmj.324.7337.573. PMID:11884321.
48. Alexa. Top sites in Italy. Available at: http://www.alexa.com/topsites/countries/IT
49. Isenberg Marketing. 2014. Google search engine market [accessed 2017May2]. https://isenbergmarketing.wordpress.com/2014/02/18/google-search-engine-market/.
50. iProspect. 2006. iProspect search engine user behaviour study [accessed 2017May2]. http://district4.extension.ifas.ufl.edu/Tech/TechPubs/WhitePaper_2006_SearchEngineUserBehavior.pdf
51. Madden K, Nan X, Briones R, Waks L. Sorting through search results: a content analysis of HPV vaccine information online. Vaccine. 2012;30(25):3741–6. doi:10.1016/j.vaccine.2011.10.025. PMID:22019758.
52. Covolo L, Mascaretti S, Caruana A, Orizio G, Caimi L, Gelatti U. How has the flu virus infected the Web? 2010 influenza and vaccine information available on the Internet. BMC Public Health. 2013;13:83. doi:10.1186/1471-2458-13-83. PMID:23360311.
53. Lucisano P, Piemontese ME. GULPEASE: a formula to predict readability of texts written in Italian language. In: [School and Town]. Brescia (Italy): La Nuova Italia; 1988. p. 3–31.
54. Allison AC. Squalene and squalane emulsions as adjuvants. Methods. 1999;19(1):87–93. doi:10.1006/meth.1999.0832. PMID:10525443.
55. Charlton-Menys V, Durrington PN. Human cholesterol metabolism and therapeutic molecules. Exp Physiol. 2008;93(1):27–42. doi:10.1113/expphysiol.2006.035147. PMID:18165431.
56. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine. 2001;19(17–19):2673–80. doi:10.1016/S0264-410X(00)00499-0. PMID:11257408.
57. Banzhoff A, Nacci P, Podda A. A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis. Gerontology. 2003;49(3):177–84. doi:10.1159/000069172. PMID:12679609.
58. Domnich A, Arata L, Amicizia D, Puig-Barberà J, Gasparini R, Panatto D. Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine. 2017;35(4):513–20. doi:10.1016/j.vaccine.2016.12.011. PMID:28024956.
59. Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine. 2009;27(49):6959–65. doi:10.1016/j.vaccine.2009.08.101. PMID:19751689.
60. Asa PB, Cao Y, Garry RF. Antibodies to squalene in Gulf War syndrome. Exp Mol Pathol. 2000;68:55–64. doi:10.1006/exmp.1999.2295. PMID:10640454.
61. Alving CR, Grabenstein JD. Letter to the editor. Exp Mol Pathol. 2000;68(3):196–7. doi:10.1006/exmp.2000.2314. PMID:10816387.
62. Maki A, Evans R, Ghezzi P. Bad news: analysis of the quality of information on influenza prevention returned by Google in English and Italian. Front Immunol. 2015;6:616. doi:10.3389/fimmu.2015.00616. PMID:26697012.
63. Cohen J. A power primer. Psychol Bull. 1992;112(1):155–9. doi:10.1037/0033-2909.112.1.155. PMID:19565683.
64. Cohen J. Statistical Power Analysis for Behavioral Sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1998.
65. Rea LM, Parker RA. Designing and Conducting Survey Research. Jossey-Boss: San Fransisco; 1992.
66. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17. doi:10.1186/1751-0473-3-17. PMID:19087314.
67. R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014 [accessed 2017May2]. http://www.R-project.org/.